Jan. 10, 2012 |
|
Dec. 17, 2018 |
|
jRCT1080221685 |
ZO-Y60 Phase III clinical trial |
|
version: date: |
Zeria Pharmaceutical Co., Ltd. |
||
03-5644-7053 |
||
Interventional |
||
3 |
||
Patients with gasstrointestinal disease. |
||
15age old over | ||
64age old under | ||
Both |
||
Gastrointestinal disease |
||
investigational material(s) |
||
ZERIA Pharmaceutical Co.,Ltd. | |
Institutional review board of Fukui Sogo Hospital | |
JapicCTI-121727 | |